Subject selection flow diagram. (1) Excluded due to inability to provide informed ... GP indicates general practitioner; OSA, obstructive sleep apnea; and PA, primary aldosteronism. Blood pressure ...

Sleep apnea may lead to weight gain by disrupting sleep, affecting hunger hormones, slowing metabolism, and more. Lifestyle ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

People who have obstructive sleep apnea may have an increased risk of dementia if left untreated, according to a new study of ...

Metabolic syndrome components were associated with higher odds of sleep apnea symptoms among adolescents and young adults in the US.

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.

People diagnosed with obstructive sleep apnea may face more than just poor sleep and tired mornings. A new study finds they ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, w | Drug Discovery And Development ...

Global warming is// expected to double the health burden of obstructive sleep apnea by the year 2100 * High number of ...

Sleep apnea affects 22 million Americans but treatments for the condition that causes snoring and impedes breathing are often inadequate. To improve treatments, a team of researchers at the ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome (OSAS) per se, although only some patients ...

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations ...